Latest Period
Q2 2026
Security Snapshot
Edesa Biotech, Inc. - Common Shares (EDSA) Institutional Ownership
CUSIP: 27966L306
13F Institutional Holders and Ownership History from Q4 2023 to Q2 2026
Institutions Reporting
33
Shares (Excl. Options)
3,754,523
Price
$8.13
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- EDSA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 3,754,523
- Total 13F value
- $31,003,275
- Portfolio coverage rank
- 0%
- Share change
- +1,109,597
- Value change
- +$9,859,915
- Number of holders
- 33
- Shares outstanding
- 13,822,304
- SEC-reported price per share
- $7.01
- Insider filing price
- $7.01
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- EDSA - Edesa Biotech, Inc. - Common Shares is tracked under CUSIP 27966L306.
- 33 institutions reported positions in Q2 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 27 to 33 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $13,826,626 to $31,003,275.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 33 institutions filings for Q2 2026.
Security key
27966L306
Latest holder period
Q2 2026
13F holders
33
13D/G owners
8
CIK / CUSIP context first
Open Q2 2026 holders
EDSA full holder history
Edesa Biotech, Inc. SEC filings
Edesa Biotech, Inc. company facts
Edesa Biotech, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 27966L306:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
EDSA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Nijhawan Pardeep | 16% | -18% | $18,320,579 | +$2,828,325 | 2,613,492 | +18% | Pardeep Nijhawan | 21 Aug 2026 |
| Velan Capital Investment Management LP | 10% | 0% | $9,508,750 | +$3,657,503 | 1,356,455 | +63% | Velan Capital Investment Management LP | 21 Aug 2026 |
| Stonepine Capital Management, LLC | 6.9% | $6,685,710 | +$6,475,410 | 953,739 | +3079% | Stonepine Capital Management, LLC | 20 Aug 2026 | |
| Rubric Capital Management LP | 7.7% | $4,056,250 | 687,500 | Rubric Capital Management LP | 31 Mar 2025 | |||
| Sirenia Capital Management LP | 7.2% | $3,540,000 | 600,000 | Sirenia Capital Management LP | 31 Mar 2026 | |||
| PERCEPTIVE ADVISORS LLC | 6.7% | $551,974 | 563,239 | Perceptive Advisors LLC | 09 Mar 2026 | |||
| INTEGRATED CORE STRATEGIES (US) LLC | 5.4% | $4,092,584 | 520,685 | Integrated Core Strategies (US) LLC | 11 Jun 2026 | |||
| Point72 Asset Management, L.P. | 0% | -103% | $11.8 | -$3,539,988 | 2 | -100% | Point72 Asset Management, L.P. | 31 Mar 2026 |
As of 30 Jun 2026, 33 institutional investors reported holding 3,754,523 shares of Edesa Biotech, Inc. - Common Shares (EDSA). This represents 27% of the company’s total 13,822,304 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
27%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 6% | 827,500 | 0% | 4.1% | $6,727,575 |
| Rubric Capital Management LP | 4.8% | 669,500 | -2.6% | 0.05% | $5,443,035 |
| PERCEPTIVE ADVISORS LLC | 4.1% | 563,239 | 0% | 0.07% | $4,579,133 |
| MILLENNIUM MANAGEMENT LLC | 4.1% | 561,751 | 0% | $4,567,036 | |
| Stonepine Capital Management, LLC | 3.3% | 456,439 | +1421% | 2.4% | $3,190,807 |
| Boxer Capital Management, LLC | 1.5% | 205,000 | 0.13% | $1,666,650 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.59% | 81,839 | -4.8% | 0% | $665,351 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.59% | 80,879 | +5% | 0% | $657,586 |
| JANE STREET GROUP, LLC | 0.52% | 72,465 | -37% | 0% | $589,141 |
| VANGUARD FIDUCIARY TRUST CO | 0.28% | 38,718 | +0.71% | 0% | $314,777 |
| STATE STREET CORP | 0.27% | 37,979 | 0% | 0% | $308,769 |
| XTX Topco Ltd | 0.26% | 35,352 | 0% | $287,412 | |
| HRT FINANCIAL LP | 0.23% | 31,531 | 0% | $256,000 | |
| BlackRock, Inc. | 0.2% | 27,495 | -0.77% | 0% | $223,534 |
| NORTHERN TRUST CORP | 0.11% | 14,994 | 0% | 0% | $121,901 |
| SCOTIA CAPITAL INC. | 0.1% | 14,393 | -9.2% | 0% | $117,015 |
| TWO SIGMA INVESTMENTS, LP | 0.1% | 14,032 | 0% | $114,080 | |
| UBS Group AG | 0.05% | 6,763 | +189% | 0% | $54,984 |
| SBI Securities Co., Ltd. | 0.03% | 3,505 | +0.09% | 0% | $28,496 |
| Federation des caisses Desjardins du Quebec | 0.02% | 2,595 | 0% | $21,097 | |
| ROYAL BANK OF CANADA | 0.01% | 1,851 | +12% | 0% | $15,000 |
| MCGUIRE CAPITAL ADVISORS INC | 0.01% | 1,500 | 0% | 0.01% | $12,195 |
| MORGAN STANLEY | 0.01% | 1,400 | 0% | $11,382 | |
| Tower Research Capital LLC (TRC) | 0.01% | 1,230 | +143% | 0% | $10,000 |
| JPMORGAN CHASE & CO | 0.01% | 1,130 | 0% | $8,667 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Latest
Q2 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 3,754,523 | $31,003,275 | +$9,859,915 | $8.13 | 33 |
| 2026 Q1 | 2,643,718 | $13,826,626 | +$763,438 | $5.23 | 27 |
| 2025 Q4 | 3,052,670 | $4,339,133 | +$168,466 | $1.42 | 21 |
| 2025 Q3 | 2,876,709 | $7,101,619 | +$1,897,089 | $2.47 | 23 |
| 2025 Q2 | 2,108,117 | $4,279,068 | -$1,739,763 | $2.03 | 20 |
| 2025 Q1 | 2,822,207 | $6,885,740 | +$6,475,156 | $2.44 | 19 |
| 2024 Q4 | 207,513 | $350,110 | +$46,292 | $1.68 | 16 |
| 2024 Q3 | 161,348 | $718,217 | +$49,169 | $4.45 | 17 |
| 2024 Q2 | 150,715 | $645,126 | +$183,339 | $4.28 | 17 |
| 2024 Q1 | 107,880 | $450,876 | -$12,949 | $4.19 | 17 |
| 2023 Q4 | 110,845 | $507,117 | +$507,117 | $4.57 | 19 |